Search research articles
Contact Us
Filters
Showing results (1-10 of 46) with videos related to
Page
of 5
Sort By:
Science'S STKE : Signal Transduction Knowledge Environment
|
March 13, 2003
Cellular distribution of Bcl-2 family proteins
Marc Germain, Gordon C Shore
Current Opinion in Drug Discovery & Development
|
April 3, 2003
Therapeutic activation of caspases in cancer: a question of selectivity
Pierre Beauparlant, Gordon C Shore
Hematology. American Society of Hematology. Education Program
|
November 24, 2005
Modulating the bcl-2 family of apoptosis suppressors for potential therapeutic benefit in cancer
Gordon C Shore, Jean Viallet
Molecular & Cellular Oncology
|
June 17, 2016
New strategies to maximize therapeutic opportunities for NAMPT inhibitors in oncology
Anne Roulston, Gordon C Shore
Cell
|
December 17, 2008
Bcl-2 proteins and apoptosis: choose your partner
Gordon C Shore, Mai Nguyen
Oncogene
|
April 13, 2004
Bcl-2 and calcium: controversy beneath the surface
Clark W Distelhorst, Gordon C Shore
Current Molecular Medicine
|
March 14, 2008
Unique biology of Mcl-1: therapeutic opportunities in cancer
Matthew R Warr, Gordon C Shore
The Journal of Biological Chemistry
|
May 2, 2003
BCL-2 selectively interacts with the BID-induced open conformer of BAK, inhibiting BAK auto-oligomerization
Salvatore C Ruffolo, Gordon C Shore
Biochimica Et Biophysica Acta
|
April 1, 2006
Mitochondrial membrane dynamics, cristae remodelling and apoptosis
Hannah M Heath-Engel, Gordon C Shore
The Journal of Biological Chemistry
|
April 6, 2005
BH3-only BIK regulates BAX,BAK-dependent release of Ca2+ from endoplasmic reticulum stores and mitochondrial apoptosis during stress-induced cell death
Jaigi P Mathai, Marc Germain, Gordon C Shore
Page
of 5
Search research articles
Search
Showing results (1-10 of 46) with videos related to
Sort By:
Page
of 5
Science'S STKE : Signal Transduction Knowledge Environment
|
March 13, 2003
Cellular distribution of Bcl-2 family proteins
Marc Germain, Gordon C Shore
Current Opinion in Drug Discovery & Development
|
April 3, 2003
Therapeutic activation of caspases in cancer: a question of selectivity
Pierre Beauparlant, Gordon C Shore
Hematology. American Society of Hematology. Education Program
|
November 24, 2005
Modulating the bcl-2 family of apoptosis suppressors for potential therapeutic benefit in cancer
Gordon C Shore, Jean Viallet
Molecular & Cellular Oncology
|
June 17, 2016
New strategies to maximize therapeutic opportunities for NAMPT inhibitors in oncology
Anne Roulston, Gordon C Shore
Cell
|
December 17, 2008
Bcl-2 proteins and apoptosis: choose your partner
Gordon C Shore, Mai Nguyen
Oncogene
|
April 13, 2004
Bcl-2 and calcium: controversy beneath the surface
Clark W Distelhorst, Gordon C Shore
Current Molecular Medicine
|
March 14, 2008
Unique biology of Mcl-1: therapeutic opportunities in cancer
Matthew R Warr, Gordon C Shore
The Journal of Biological Chemistry
|
May 2, 2003
BCL-2 selectively interacts with the BID-induced open conformer of BAK, inhibiting BAK auto-oligomerization
Salvatore C Ruffolo, Gordon C Shore
Biochimica Et Biophysica Acta
|
April 1, 2006
Mitochondrial membrane dynamics, cristae remodelling and apoptosis
Hannah M Heath-Engel, Gordon C Shore
The Journal of Biological Chemistry
|
April 6, 2005
BH3-only BIK regulates BAX,BAK-dependent release of Ca2+ from endoplasmic reticulum stores and mitochondrial apoptosis during stress-induced cell death
Jaigi P Mathai, Marc Germain, Gordon C Shore
Page
of 5